Cart
sales@molnova.com
Biotin-PEG3-NHS ester
CAS No. 1253286-56-4
Biotin-PEG3-NHS ester( —— )
Catalog No. M33293 CAS No. 1253286-56-4
Biotin-PEG3-NHS ester is a PROTAC linker based on the PEG structure that facilitates the preparation of PROTAC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 58 | In Stock |
|
| 100MG | 91 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBiotin-PEG3-NHS ester
-
NoteResearch use only, not for human use.
-
Brief DescriptionBiotin-PEG3-NHS ester is a PROTAC linker based on the PEG structure that facilitates the preparation of PROTAC.
-
DescriptionBiotin-PEG3-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTAC.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein.PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1253286-56-4
-
Formula Weight544.62
-
Molecular FormulaC23H36N4O9S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (183.61 mM )
-
SMILESC(CCCC(NCCOCCOCCOCCC(ON1C(=O)CCC1=O)=O)=O)[C@H]2[C@@]3([C@](CS2)(NC(=O)N3)[H])[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
cis-Mulberroside A
cis-Mulberroside A shows high analgesic and anti-inflammatory activities, it can protect mice against ethanol-induced hepatic damage.
-
(3,4-Dihydroxyphenyl...
The herbs of Gastrodia elata BL.
-
20-Hydroxylucidenic ...
20-Hydroxylucidenic acid E2 is a triterpenoid compound found in Ganoderma lucidum. It exhibits significant inhibitory effects on inflammation induced by TPA . Additionally, 20-Hydroxylucidenic acid E2 can suppress the expression of EBV early antigen induced by TPA , with a IC50 of 290 mol ratio/32 pmol TPA (meaning that when the molar concentration of this compound is 290 times that of 32 pmol of TPA, it can inhibit 50% of EBV early antigen expression). Therefore, 20-Hydroxylucidenic acid E2 has potential applications in anti-inflammatory and anticancer research.
